Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 5 (2008), Issue 10 (October)

1. Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha.
   Blood, 112(8): 3339-47. [Abstract] [Full-text]
2. Survival patterns among lymphoma patients with a family history of lymphoma.
   J Clin Oncol, 26(30): 4958-65. [Abstract] [Full-text]
3. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
   Cancer Genet Cytogenet, 186(2): 110-4. [Abstract] [Full-text]
4. A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma.
   Ann Oncol, 19(11): 1941-6. [Abstract] [Full-text]
5. Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy.
   Ann Oncol, 19(11): 1915-20. [Abstract] [Full-text]
6. Expression and function of T cell homing molecules in Hodgkin's lymphoma.
   Cancer Immunol Immunother, 58(1): 85-94. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.